Why does the Taiwanese government place such importance on the biomedical industry?

Besides market growth due to an aging population, the autonomy of the pharmaceutical supply chain is considered a matter of national resilience.

How might this policy impact Japanese companies?

Increased collaboration between Taiwan's ICT and biomedical firms could create more opportunities for Japanese companies in terms of partnerships and investment.

AI News NQ Analysis

Biomedical Industry as Taiwan's Next 'Sacred Mountain'; NDC Encourages AI Applications and Personalized Medicine

NQ Score 0/100

N1 Content Completeness 0.9

AI Summary (NQ-processed)

Deputy Minister Jan Fang-kuan of the National Development Council (NDC) stated on the 5th that the biomedical market will expand in response to Taiwan's declining birthrate and aging population. The government will focus on three development directions: CDMO, personalized medicine (precision and regenerative medicine), and smart healthcare leveraging the ICT industry's strengths with AI applications. Jan emphasized that the biomedical industry is crucial for national resilience and called for rational public understanding.

AI Analysis

Frequently Asked Questions

Q: What are the core directions of Taiwan's biomedical industry policy?: A: The three core directions are CDMO, personalized medicine (precision and regenerative medicine), and smart healthcare leveraging ICT.
Q: Why does the Taiwanese government place such importance on the biomedical industry?: A: Besides market growth due to an aging population, the autonomy of the pharmaceutical supply chain is considered a matter of national resilience.
Q: How might this policy impact Japanese companies?: A: Increased collaboration between Taiwan's ICT and biomedical firms could create more opportunities for Japanese companies in terms of partnerships and investment.